Friday, January 24, 2025

Is This Defense Stock a Ticking Time Bomb?

Shield

AN OXFORD CLUB PUBLICATION

Loyal reader since December 2024

Wealthy Retirement

View in browser

SPONSORED

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Businessman in black suit
 

In 1999, Sutter Hill Ventures made a bold bet on Nvidia before anyone had heard of it. Now, they're going all-in on Nvidia's hush-hush partner that's powering their new Blackwell chip. Discover the little-known company that's attracting massive investments from the visionaries behind Nvidia's 100,000% rise. Unlock the hidden key to AI's future.

Is Leidos Stock a Ticking Time Bomb?

Anthony Summers, Director of Trading, The Oxford Club

Anthony Summers

In the high-stakes world of defense contracting, few names carry as much weight as Leidos Holdings (NYSE: LDOS). The Virginia-based technology leader has built a formidable business providing mission-critical solutions to government agencies and commercial customers.

From cybersecurity and artificial intelligence to healthcare services and logistics support, Leidos touches nearly every aspect of national security and civilian infrastructure.

The stock has been on quite a roller coaster ride lately.

Chart: Leidos Holdings (NYSE: LDOS)
View larger image
 

After surging to a peak of over $200 in late 2024 amid heightened global security concerns, shares took a sharp tumble below $150 by year-end. But aside from a sell-off yesterday (which was caused by industrywide factors rather than anything company-specific), the stock appears to have found its footing again.

The company's latest results are certainly worth noting. It just posted a stellar third quarter, with revenues jumping 7% year over year to $4.19 billion. Even more impressive was its adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margin of 14.2% - a new record that showcases the company's improving operational efficiency.

Leidos also generated robust free cash flow of $633 million and secured $8.1 billion in new bookings, bringing its total backlog to a whopping $40.6 billion.

Management's recent actions suggest strong confidence in the business too. They've hiked the quarterly dividend by 5.3% and, through three quarters, had already completed $450 million of their planned $500 million share repurchase program for the year.

The company also announced two major contracts earlier this week: a $120 million cybersecurity deal with the Department of Defense and a $2.6 billion contract to maintain Transportation Security Equipment at over 430 U.S. airports.

So, while investors may be concerned about the defense sector as a whole... the company itself is thriving.

This is a great example of how The Value Meter can help keep us grounded amid a flurry of news.

But before I reveal Leidos' Value Meter score, I want to hear from you.

What do you think about the stock's valuation? Would you consider buying it at current levels?

Click the button below to share your thoughts in the comment section. Then, scroll up to finish reading and find out Leidos' score.

Get Leidos' Score Here

SPONSORED

SIX AI Dividend Stocks to Buy Now (FREE INSIDE)

Marc Lichtenfeld - income expert and author of Get Rich with Dividends - is giving away his Free AI Income Playbook...

No credit card required!

Inside, you'll get the names and ticker symbols of his TOP SIX AI dividend stocks right now, including...

  • A special income play that pays double-digit yield
  • How to get into an AI income trust
  • And finally, Marc's No. 1 dividend stock for AI income.

Click here before the download link expires.

3-Minute Stock Secret Message: Learn the Little-Used Technique That Delivered Gains up to 227% in a Single Month

How Millionaires Reach Seven Figures

Gold at $2,500/Oz, but This Investment Gives You More for Just $20. How?

Deregulation Could Keep This Bull Market Roaring

SPONSORED

Better Than Oil Stocks

Click Here to Play
 

The best way to profit from energy is NOT a stock...

Rather, it's this little-known alternative investment.

CLICK HERE TO FIND OUT MORE

No comments:

Post a Comment